2026 Q1 Portfolio Activity
In 2026 Q1, Lion Point Capital, LP maintained a portfolio of 39 distinct positions. They heavily accumulated shares in COMPASS PATHWAYS PLC, increasing the position by 37.9%. Conversely, Lion Point Capital, LP completely exited their position in DAY ONE BIOPHARMACEUTICALS I.
Position History
hover any row below to update
Loading…
Total Positions
39
Quarter
2026 Q1
Top Holding
PRAX (8.6%)
Top 10 Concentration
54.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-39 of 39
Lion Point Capital, LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 8.57% | 6.79% |
#1
1
Prev: #2
|
6.4 |
—
|
no change | no change |
P
S
|
4,450 | $1,433,746 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 7.52% | 4.60% |
#2
1
Prev: #3
|
5.5 |
—
|
no change | no change |
P
S
|
67,500 | $1,258,200 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RPRX
ROYALTY PHARMA ...
|
Healthcare | 6.14% | 4.28% |
#3
4
Prev: #7
|
4.5 |
—
|
no change | no change |
P
S
|
21,400 | $1,026,558 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MIST
MILESTONE PHARM...
|
Healthcare | 5.83% | 7.89% |
#4
3
Prev: #1
|
4.8 |
—
|
65,000 | 8.6% |
P
S
|
820,000 | $975,800 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GERN
GERON CORP
|
Healthcare | 5.15% | 3.95% |
#5
3
Prev: #8
|
3.6 |
—
|
no change | no change |
P
S
|
578,000 | $861,220 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 5.03% | 3.91% |
#6
3
Prev: #9
|
3.0 |
—
|
no change | no change |
P
S
|
36,000 | $840,960 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 4.61% | 3.88% |
#7
3
Prev: #10
|
2.8 |
—
|
no change | no change |
P
S
|
128,650 | $770,614 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FENC
FENNEC PHARMACE...
|
Healthcare | 4.13% | 4.48% |
#8
4
Prev: #4
|
2.7 |
—
|
no change | no change |
P
S
|
112,434 | $691,469 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BNTC
BENITEC BIOPHAR...
|
Healthcare | 3.95% | 4.32% |
#9
3
Prev: #6
|
2.6 |
—
|
no change | no change |
P
S
|
62,000 | $660,300 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SRPT
SAREPTA THERAPE...
|
Healthcare | 3.71% | 3.17% |
#10
3
Prev: #13
|
2.5 |
—
|
no change | no change |
P
S
|
28,500 | $620,160 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 3.10% | 3.33% |
#11
1
Prev: #12
|
2.2 |
—
|
no change | no change |
P
S
|
8,100 | $517,914 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CUE
CUE BIOPHARMA I...
|
Healthcare | 3.03% | 3.48% |
#12
1
Prev: #11
|
2.2 |
—
|
no change | no change |
P
S
|
2,202,854 | $506,436 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 2.64% | 2.07% |
#13
5
Prev: #18
|
3.6 |
—
|
22,000 | 37.9% |
P
S
|
80,000 | $442,400 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 2.61% | 3.02% |
#14
Prev: #14
|
2.0 |
—
|
no change | no change |
P
S
|
51,700 | $437,382 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 2.49% | 1.89% |
#15
9
Prev: #24
|
2.0 |
—
|
no change | no change |
P
S
|
5,500 | $417,175 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JSPR
JASPER THERAPEU...
|
Healthcare | 2.44% | 4.40% |
#16
11
Prev: #5
|
2.0 |
—
|
no change | no change |
P
S
|
465,000 | $407,433 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HUMA
HUMACYTE INC
|
Healthcare | 2.36% | 2.49% |
#17
2
Prev: #15
|
3.4 |
—
|
150,000 | 30.0% |
P
S
|
650,000 | $394,355 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VTRS
VIATRIS INC
|
Healthcare | 2.24% | 1.78% |
#18
10
Prev: #28
|
1.9 |
—
|
no change | no change |
P
S
|
27,700 | $374,227 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 2.24% | 2.47% |
#19
3
Prev: #16
|
1.9 |
—
|
no change | no change |
P
S
|
46,000 | $373,980 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 2.22% | 1.98% |
#20
1
Prev: #21
|
1.9 |
—
|
no change | no change |
P
S
|
5,000 | $371,300 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.95% | 1.82% |
#21
4
Prev: #25
|
1.8 |
—
|
no change | no change |
P
S
|
18,000 | $326,340 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RCKT
ROCKET PHARMACE...
|
Healthcare | 1.84% | 1.56% |
#22
8
Prev: #30
|
1.7 |
—
|
no change | no change |
P
S
|
86,000 | $307,880 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PCRX
PACIRA BIOSCIEN...
|
Healthcare | 1.82% | 1.81% |
#23
4
Prev: #27
|
1.7 |
—
|
no change | no change |
P
S
|
13,500 | $305,100 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.71% | 1.17% |
#24
8
Prev: #32
|
1.7 |
—
|
no change | no change |
P
S
|
9,100 | $286,650 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 1.70% | 1.97% |
#25
3
Prev: #22
|
1.7 |
—
|
no change | no change |
P
S
|
10,500 | $284,445 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MCRB
SERES THERAPEUT...
|
Healthcare | 1.67% | 2.43% |
#26
9
Prev: #17
|
1.7 |
—
|
no change | no change |
P
S
|
31,570 | $280,026 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 1.58% | 1.36% |
#27
4
Prev: #31
|
1.6 |
—
|
no change | no change |
P
S
|
19,000 | $264,100 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
QURE
UNIQURE NV
|
Healthcare | 1.44% | 1.82% |
#28
2
Prev: #26
|
1.6 |
—
|
no change | no change |
P
S
|
14,700 | $240,345 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RGNX
REGENXBIO INC
|
Healthcare | 1.33% | 1.98% |
#29
9
Prev: #20
|
1.5 |
—
|
no change | no change |
P
S
|
26,600 | $222,908 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AZTA
AZENTA INC
|
Healthcare | 1.22% | 1.67% |
#30
1
Prev: #29
|
1.5 |
—
|
no change | no change |
P
S
|
9,700 | $204,961 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INVA
INNOVIVA INC
|
Healthcare | 1.14% | 0.85% |
#31
2
Prev: #33
|
1.5 |
—
|
no change | no change |
P
S
|
8,200 | $191,060 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GHRS
GH RESEARCH PLC
|
Healthcare | 0.86% | 0.67% |
#32
5
Prev: #37
|
1.3 |
—
|
no change | no change |
P
S
|
10,200 | $143,412 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 0.74% | 0.79% |
#33
1
Prev: #34
|
1.3 |
—
|
no change | no change |
P
S
|
5,250 | $123,690 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IPHA
INNATE PHARMA S...
|
Healthcare | 0.62% | 0.73% |
#34
1
Prev: #35
|
1.2 |
—
|
no change | no change |
P
S
|
81,151 | $103,873 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SPRB
SPRUCE BIOSCIEN...
|
Healthcare | 0.39% | 0.45% |
#35
3
Prev: #38
|
1.2 |
—
|
no change | no change |
P
S
|
1,000 | $65,350 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MRSN
MERSANA THERAPE...
|
Unknown | 0.00% | 0.01% |
Sold All 😨
(Was: #39) |
0.0 |
—
|
-100 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NERV
MINERVA NEUROSC...
|
Healthcare | 0.00% | 0.73% |
Sold All 😨
(Was: #36) |
0.0 |
—
|
-35,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VTYX
VENTYX BIOSCIEN...
|
Healthcare | 0.00% | 1.94% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-41,500 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DAWN
DAY ONE BIOPHAR...
|
Healthcare | 0.00% | 2.03% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-42,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-39 of 39 holdings